To validate our findings that PPAT-GLS1 balance influences cancer malignancy in cells and in mice, we examined the relation of PPAT and GLS1 gene expression to overall survival in single cohorts of lung, brain, or neuroendocrine cancer patients (Supplementary Fig. 11a). The gene discussed is PPAT; the disease is neuroendocrine carcinoma.